Key result
ML-derived Phenotype 3 linked to ~236% higher 28-day mortality in VA-ECMO cardiogenic shock.
Why the study?
Outcomes remain heterogeneous despite the widespread use of VA-ECMO for cardiogenic shock, prompting the identification of clinically meaningful phenotypes and their prognostic value.
Does machine learning-derived phenotyping improve prognostic stratification for 28-day mortality in patients with cardiogenic shock undergoing VA-ECMO?
Cohort (n=135)
Does machine learning-derived phenotyping improve prognostic stratification for 28-day mortality in patients with cardiogenic shock undergoing VA-ECMO?
Machine learning-derived phenotyping identifies a high-risk subgroup of cardiogenic shock patients on VA-ECMO and improves mortality risk stratification beyond established clinical scores.
Answers are grounded in this paper and cite their sources.
Phenotype 3 was associated with higher mortality; hypothesis-generating for clustering-based risk stratification in VA-ECMO, needs prospective validation.
Background: Cardiogenic shock (CS) is a life-threatening condition marked by inadequate cardiac output and systemic hypoperfusion. Despite widespread use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) for CS, outcomes remain heterogeneous. We sought to identify clinically meaningful phenotypes and assess their prognostic value in patients receiving VA-ECMO. Methods: In this retrospective study of 135 patients with CS treated with VA-ECMO, unsupervised machine learning using factor analysis of mixed data followed by clustering was applied to baseline clinical, hemodynamic, and biochemical variables. Incremental prognostic value was evaluated by comparing Cox models with and without phenotype assignment, adjusting for the SAVE score, vasoactive-inotropic score (VIS), and prior medical history. Discrimination was assessed using Harrell’s C-index with 1,000-bootstrap validation. Results: Three phenotypes were identified. Phenotype 3 (n=29) exhibited severe hemodynamic instability, higher VIS, and marked hyperlactatemia. After optimism correction, the phenotype-enhanced model achieved a C-index of 0.706 (95% CI 0.684–0.719) versus 0.677 (95% CI 0.654–0.686) for the baseline model (ΔC-index 0.029). Phenotype 3 was independently associated with increased 28-day mortality (adjusted hazard ratio 3.36, 95% CI 1.50–7.54), whereas phenotype 2 did not differ from phenotype 1. Conclusion: Machine learning–derived phenotypes stratify mortality risk in CS patients receiving VA-ECMO and provide incremental prognostic information beyond established scores.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Cardiogenic shock (n=135). Machine learning-derived Phenotype 3 vs. Phenotype 1 was evaluated on 28-day mortality (adjusted HR 3.36, 95% CI 1.50-7.54). Machine learning-derived Phenotype 3 was independently associated with increased 28-day mortality in cardiogenic shock patients receiving VA-ECMO (adjusted HR 3.36; 95% CI 1.50-7.54).
Synapse has enriched 10 related papers. Consider them for comparative context: